Vincent specializes in strain characterization and therapeutic efficacy studies with expertise in neurodevelopmental and skeletal disorders. With extensive research experience in molecular biology and neuroscience, he leads programs from novel model development and characterization through IND-enabling therapeutics studies. Vincent’s work is motivated by the mission of improving outcomes for families facing rare conditions.
Vincent received his B.S. in molecular and cell biology and an M.S. in clinical and translational research from the University of Montpellier in France. Vincent studied molecular medicine and neuroscience for his Ph.D. at the University Laval in Canada before also earning his MBA from Husson University. In addition to his robust research experience, Vincent has also worked as a Clinical Research Associate for Orion Clinical Research and Syneos Health (formerly known as InVentiv Health Clinical) before joining the JAX Rare Disease Translational Center as a Study Director.